Top Markets
#1 Nesa Nesa +720.45%
#2 EXOD EXOD +22.78%
#3 MetaDAO MetaDAO +14.20%
#4 Venom Venom +10.71%
#5 Pons Pons +9.49%
#6 Prom Prom +9.20%
#7 PondCoin PondCoin +8.29%
#8 Status Status +8.08%
#9 Wrapped NXM Wrapped NXM +7.61%
#10 Kinesis Silver Kinesis Silver +6.89%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rank in Stocks #19834
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Share Price
$9.61
Last synced: 2026-08-25
Market Cap
$149.33M
Change (1 day)
-1.39%
Change (1 year)
21.24%
Country
US
Trade Alpha Cognition Inc (ACOG)

Category

Healthcare
Earnings for Alpha Cognition Inc (ACOG)
Earnings in 2026 TTM: 0
According to Alpha Cognition Inc latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Alpha Cognition Inc from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH